We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Lifotronic Technology Co., Ltd.

Lifotronic designs, develops, and manufactures medical devices, specializing in bedside treatment and diagnostic prod... read more Featured Products: More products

Download Mobile App





Lifotronic Demonstrates Latest Medical Innovations in Disease Diagnostics

By LabMedica International staff writers
Posted on 06 Feb 2024

Lifotronic (Shenzhen, China) is demonstrating its latest medical innovations, including its CLIA, HPLC, CBC, and POCT solutions, at Medlab Middle East 2024. More...

Lifotronic is presenting a comprehensive range of solutions for large, medium, and small-sized laboratories to a global audience of experts and scholars at the show. Lifotronic’s eCL8000, dubbed the king of emergency, is one of the featured technology products at the exhibition. eCL 8000 is an 86 T/H fully automated analyzer based on the most advanced Electro-chemiluminescence Immunoassay (ECLIA). More than 90 parameters are available, covering thyroid, fertility, tumor, cardiac, inflammation, bone metabolism markers, etc. At Medlab Middle East 2024, Lifotronic is introducing its latest product, the eCL9000 electro-chemiluminescence analyzer which is designed especially for large labs, hospitals, and chain labs. It can perform 300 tests per hour at a constant speed, meeting the high demand of more than 100 samples per day. It also allows end users to easily conduct immunoassay tests. With a super long walkaway time of 5.5 hours, it frees up the operator’s time, improves work efficiency, and creates a more relaxed and flexible work environment.

Lifotronic is also showcasing its latest H100 high-pressure liquid chromatography analyzer which has a test speed of 96s/T. Convenient, fast, and accurate, it also has a one-click switch function for HbA1c and thalassemia modes. H100 can greatly improve the analysis process and achieve the ideal balance of quality, efficiency, and cost. In addition, Lifotronic is highlighting the AC310 and AC610 hematology analyzers which are widely recognized for their stable performance. These analyzers not only provide accurate and reliable clinical data for doctors but also offer patients a higher level of medical services. The AC630 hematology analyzer is the latest addition to the hematology analyzer series and its fully automated operation significantly improves the laboratory’s operational efficiency, as well as brings greater convenience to the operator. Lifotronic is also showcasing its complete solution for POCT using fluorescence immunochromatography and colloidal gold rapid detection. The POCT fluorescence immunochromatography analyzer offers several test parameters, is easy to carry, and enables fast detection. Its single-use cartridge design can satisfy the needs of primary healthcare facilities and small to medium-sized labs with low sample volumes.

Related Links:
Lifotronic


Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
C-Reactive Protein Assay
OneStep C-Reactive Protein (CRP) RapiCard InstaTest
New
Typhoid Rapid Test
OnSite Typhoid IgG/IgM Combo Rapid Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Pathology

view channel
Image: AI-analyzed images from the FDM microscope show platelet clumps in motion (Photo courtesy of Hirose et al CC-BY-ND)

AI Microscope Spots Deadly Blood Clots Before They Strike

Platelets are small blood cells that act as emergency responders in the body, rushing to areas of injury to help stop bleeding by forming clots. However, sometimes platelets can overreact, leading to complications.... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
MEDLAB 2024
Copyright © 2000-2025 Globetech Media. All rights reserved.